.Adhering to a poor revealing for Lykos Therapeutics' MDMA candidate for trauma at a current FDA con...
.AN2 Therapies is rethinking its business in action to poor midphase records, promising to give up h...
.Merck & Co. is paying $700 million upfront to challenge Amgen in a blood stream cancer cells mar...
.Along With Gilead Sciences about to an FDA decision for its own liver disease drug seladelpar, the ...
.CEO David Ricks can find the business putting together outdoors tents at basecamp behind Eli Lilly ...
.Bed mattress Liquidators has actually turned Entero Therapeutics white colored as a sheet. The lend...
.Exelixis is surrendering on its own cells factor (TF)- targeting antibody-drug conjugate after conc...
.Three full weeks after Roche's Genentech device walked away from an SHP2 inhibitor treaty, Relay Th...
.Stoke Therapeutics' Dravet disorder drug has actually been devoid of a partial grip, removing the w...
.Strong Biotech Colleague Publisher Gabrielle Masson showed the 2024 course of Intense 15 victors on...